CONCENTRIX ($CNXC) posted quarterly earnings results for Q3 2026 on Tuesday, September 29th. The company reported earnings of $2.92 per share, beating estimates of $2.76 by $0.16. The company also reported revenue of $2,453,680,000, missing estimates of $2,525,956,815 by $-72,276,815.
Stock price change since market close: -5.31%
You can see Quiver Quantitative's $CNXC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CONCENTRIX Insider Trading Activity
CONCENTRIX insiders have traded $CNXC stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CNXC stock by insiders over the last 6 months:
- BRUXELLES LAMBERT GROUPE sold 6,000,000 shares for an estimated $133,500,000
- ANDRE S VALENTINE (Chief Financial Officer) purchased 2,500 shares for an estimated $69,869
- CHRISTOPHER A CALDWELL (President and CEO) purchased 1,000 shares for an estimated $21,249
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CONCENTRIX Hedge Fund Activity
We have seen 147 institutional investors add shares of CONCENTRIX stock to their portfolio, and 230 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GROUPE BRUXELLES LAMBERT removed 6,000,000 shares (-68.4%) from their portfolio in Q2 2026, for an estimated $134,430,000
- BLACKROCK, INC. added 2,616,644 shares (+64.4%) to their portfolio in Q2 2026, for an estimated $58,625,908
- AQR CAPITAL MANAGEMENT LLC removed 1,559,784 shares (-32.3%) from their portfolio in Q2 2026, for an estimated $34,946,960
- KOPERNIK GLOBAL INVESTORS, LLC added 1,548,460 shares (+95.2%) to their portfolio in Q2 2026, for an estimated $34,693,246
- FMR LLC added 1,489,652 shares (+35.3%) to their portfolio in Q2 2026, for an estimated $33,375,653
- CITADEL ADVISORS LLC added 1,124,167 shares (+1093.4%) to their portfolio in Q1 2026, for an estimated $30,757,209
- UBS GROUP AG added 879,754 shares (+38.5%) to their portfolio in Q2 2026, for an estimated $19,710,888
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CONCENTRIX Analyst Ratings
Wall Street analysts have issued reports on $CNXC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 06/30/2026
To track analyst ratings and price targets for CONCENTRIX, check out Quiver Quantitative's $CNXC forecast page.
CONCENTRIX Price Targets
Multiple analysts have issued price targets for $CNXC recently. We have seen 4 analysts offer price targets for $CNXC in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- David Koning from Baird set a target price of $30.0 on 06/30/2026
- Luke Morison from Canaccord Genuity set a target price of $45.0 on 06/30/2026
- Vincent Colicchio from Barrington Research set a target price of $30.0 on 06/30/2026
- Ruplu Bhattacharya from B of A Securities set a target price of $26.0 on 06/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
